Ho S N, Biggar S R, Spencer D M, Schreiber S L, Crabtree G R
Department of Pathology, Howard Hughes Medical Institute, Stanford University School of Medicine, California 94305, USA.
Nature. 1996 Aug 29;382(6594):822-6. doi: 10.1038/382822a0.
Eukaryotic transcriptional activators mediate transcriptional induction through stabilization of the preinitiation complex, probably through direct interactions with basal transcription factors. In vitro studies on the role of an activator in the maintenance of on-going transcription (reinitiation) have been contradictory, suggesting that, after formation of a preinitiation complex, an activator may or may not be necessary for transcription to be maintained. We have developed a means of regulating transcription in living cells through the use of both homodimeric and heterodimerizing synthetic ligands that allow the ligand-dependent association and disassociation of a transcriptional activation domain with a promoter. Here we report that maintaining the transcription of endogenous genes in vivo, in both yeast and human cells, requires the continuous presence of the activation domain. The use of synthetic ligands as a transcriptional on-off switch represents a powerful means of controlling the transcription in vitro and in vivo for both experimental and therapeutic purposes.
真核转录激活因子通过稳定前起始复合物介导转录诱导,可能是通过与基础转录因子的直接相互作用来实现的。关于激活因子在维持正在进行的转录(重新起始)中的作用的体外研究结果相互矛盾,这表明在前起始复合物形成后,激活因子对于维持转录可能是必要的,也可能不是。我们已经开发出一种通过使用同二聚体和异二聚化合成配体来调节活细胞中转录的方法,这些配体允许转录激活结构域与启动子进行配体依赖性的结合和解离。在此我们报告,在酵母和人类细胞中,在体内维持内源性基因的转录需要激活结构域的持续存在。使用合成配体作为转录开关代表了一种用于实验和治疗目的、在体外和体内控制转录的强大方法。